LCTX gets upgrade and is technically setup LONGLCTX on the weekly chart here has been falling since late 2021 and found support at the bottom
of the high volume area of the volume profile and ranged between it and the POC line for the
past 18 months. The is a high end clinically active biotechnology firm using stem cells to
produce therapeutic cell lines . ( One experiment using the mammary glands of cows imbedded
with cells that make insulin to make a weak milk solution containing insulin and then
concentrate it for cheap insulin is quite remarkable- ) How about some special milk for
to have with your sugar buzz) see more in the here link en.wikipedia.org
Anyway, price rose into triple confluence- the anchored mean VWAP, the POC line, the upper
boundary of the high volume area. A new analysis targets 7. Smart money is paying attention.
My smart money is paying a lot of attention. I understand the science and the market that
LCTX could reach in due time. I am not an insider but close. Enough said. My target is the
tweezer tops of 2022 at 2.5 and so 65-70% upside in the near to intermediate term and after
that maybe the analysis will revise the target up or down I am guessing the former.
